Have a personal or library account? Click to login
Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19–20 and WHF COVID-19 CVD Studies Cover

Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19–20 and WHF COVID-19 CVD Studies

Global Heart
Volume 20 (2025): Issue 1
By: Juan Esteban Gómez-Mesa,  Juan Pablo Arango-Ibanez,  Pablo Perel,  Dorairaj Prabhakaran,  Hoover O. León-Giraldo,  Alejandro Toro-Pedroza,  Ricardo Enrique Larrea Gómez,  César J. Herrera,  Julián Lugo-Peña,  Liliana Patricia Cárdenas Alaz,  Victor Rossel,  Daniel Sierra-Lara,  Jessica Mercedes,  Clara Inés Saldarriaga-Giraldo,  María Juliana Rodríguez-González,  Armando Alvarado,  Juan Carlos Ortega,  Miguel Quintana Da Silva,  Kavita Singh,  Karen Sliwa and  On behalf of the CARDIO COVID 19–20 and WHF CVD COVID-19 research groups  
Open Access
|Feb 2025

References

  1. 1Ayouni I, Maatoug J, Dhouib W, Zammit N, Fredj SB, Ghammam R, et al. Effective public health measures to mitigate the spread of COVID-19: a systematic review. BMC Public Health. 2021 May 29;21(1):1015. DOI: 10.1186/s12889-021-11111-1
    Back to article
  2. 2WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2024 Jun 8]. Available from: https://covid19.who.int.
    Back to article
  3. 3Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, Janani M, Sepandi M. Case fatality rate of COVID-19: a systematic review and meta-analysis. J Prev Med Hyg. 2021 Jun;62(2):E311–20. DOI: 10.15167/2421-4248/jpmh2021.62.2.1627
    Back to article
  4. 4Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Aug 21;21(1):855. DOI: 10.1186/s12879-021-06536-3
    Back to article
  5. 5Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021 Jan 11;11(1):e044640. DOI: 10.1136/bmjopen-2020-044640
    Back to article
  6. 6Kharroubi SA, Diab-El-Harake M. Sex-differences in COVID-19 diagnosis, risk factors and disease comorbidities: A large US-based cohort study. Front Public Health. 2022 Nov 17 [cited 2024 Jul 26];10:1029190. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714345/. DOI: 10.3389/fpubh.2022.1029190
    Back to article
  7. 7Qi S, Ngwa C, Morales Scheihing DA, Al Mamun A, Ahnstedt HW, Finger CE, et al. Sex differences in the immune response to acute COVID-19 respiratory tract infection. Biol Sex Differ. 2021 Dec 20;12:66. DOI: 10.1186/s13293-021-00410-2
    Back to article
  8. 8CDCMMWR. Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2020 [cited 2024 Aug 6];69. Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e4.htm. DOI: 10.15585/mmwr.mm6915e4
    Back to article
  9. 9Bonnet F, Grigoriev P, Sauerberg M, Alliger I, Mühlichen M, Camarda CG. Spatial disparities in the mortality burden of the covid-19 pandemic across 569 European regions (2020–2021). Nat Commun. 2024 May 18;15(1):4246. DOI: 10.1038/s41467-024-48689-0
    Back to article
  10. 10Brown PA. Country-level predictors of COVID-19 mortality. Sci Rep. 2023 Jun 7;13(1):9263. DOI: 10.1038/s41598-023-36449-x
    Back to article
  11. 11Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Glob Health. 2022 May 1;7(5):e008477. DOI: 10.1136/bmjgh-2022-008477
    Back to article
  12. 12Gómez-Mesa JE, Galindo-Coral S, Montes MC, Alarco W, Barisani JL, Magaña A, et al. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Glob Heart. 2021 Feb 12;16(1):14. DOI: 10.5334/gh.1272
    Back to article
  13. 13Sliwa K, Singh K, Raspail L, Ojji D, Lam CSP, Thienemann F, et al. The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease. Glob Heart. 16(1):22. DOI: 10.5334/gh.950
    Back to article
  14. 14World Health Organization. Hospital beds (per 10 000 population) [Internet]. [cited 2024 Jul 26]. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hospital-beds-(per-10-000-population).
    Back to article
  15. 15Baptista A, Vieira AM, Capela E, Julião P, Macedo A. COVID-19 fatality rates in hospitalized patients: A new systematic review and meta-analysis. J Infect Public Health. 2023 Oct;16(10):1606–12. DOI: 10.1016/j.jiph.2023.07.006
    Back to article
  16. 16Prabhakaran D, Singh K, Kondal D, Raspail L, Mohan B, Kato T, et al. Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study. Glob Heart. 17(1):40. DOI: 10.5334/gh.1128
    Back to article
  17. 17Gomez-Mesa JE, Galindo S, Escalante-Forero M, Rodas Y, Valencia A, Perna E, et al. Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results. Glob Heart. 2023;18(1):60. DOI: 10.5334/gh.1272
    Back to article
  18. 18Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health. 2020 Dec;45(6):1270–82. DOI: 10.1007/s10900-020-00920-x
    Back to article
  19. 19Hahnle L, Mennen M, Gumedze F, Mutithu D, Adriaanse M, Egan D, et al. Greater Disease Severity and Worse Clinical Outcomes in Patients Hospitalised with COVID-19 in Africa. Glob Heart. 2024;19(1):34. DOI: 10.5334/gh.1314
    Back to article
  20. 20Hughes GD, Mbamalu ON, Okonji CO, Puoane TR. The Impact of Health Disparities on COVID-19 Outcomes: Early Findings from a High-Income Country and Two Middle-Income Countries. J Racial Ethn Health Disparities. 2022;9(1):376–83. DOI: 10.1007/s40615-021-00999-5
    Back to article
  21. 21Janke AT, Mei H, Rothenberg C, Becher RD, Lin Z, Venkatesh AK. Analysis of Hospital Resource Availability and COVID-19 Mortality Across the United States. J Hosp Med. 2021 Apr;16(4):211–4. DOI: 10.12788/jhm.3539
    Back to article
  22. 22Liang CK, Chen LK. National health care quality and COVID-19 case fatality rate: International comparisons of top 50 countries. Arch Gerontol Geriatr. 2022;98:104587. DOI: 10.1016/j.archger.2021.104587
    Back to article
  23. 23Sharma M, Bhargava A, Szpunar SM, Johnson LB, Saravolatz LD. Do risk factors at the time of hospital admission differ by sex for in-hospital mortality from coronavirus disease 2019 (COVID-19)? Antimicrob Steward Healthc Epidemiol ASHE. 2021 Nov 25;1(1):e55. DOI: 10.1017/ash.2021.223
    Back to article
  24. 24Jun T, Nirenberg S, Weinberger T, Sharma N, Pujadas E, Cordon-Cardo C, et al. Analysis of sex-specific risk factors and clinical outcomes in COVID-19. Commun Med. 2021 Jun 30;1:3. DOI: 10.1038/s43856-021-00006-2
    Back to article
  25. 25Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health. 2021 Dec 16;6(12):e006434. DOI: 10.1136/bmjgh-2021-006434
    Back to article
  26. 26Palaiodimos L, Chamorro-Pareja N, Karamanis D, Li W, Zavras PD, Chang KM, et al. Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Horm Athens Greece. 2021 Jun;20(2):305–14. DOI: 10.1007/s42000-020-00246-2
    Back to article
  27. 27Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID–19 and chronic kidney disease: an updated overview of reviews. J Nephrol. 2022;35(1):69–85. DOI: 10.1007/s40620-021-01206-8
    Back to article
  28. 28Marmor HN, Pike M, Zhao ZA, Ye F, Deppen SA. Risk factors for SARS-CoV-2 related mortality and hospitalization before vaccination: A meta-analysis. PLOS Glob Public Health. 2022;2(11):e0001187. DOI: 10.1371/journal.pgph.0001187
    Back to article
  29. 29Salaffi F, Carotti M, Tardella M, Borgheresi A, Agostini A, Minorati D, et al. The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia. Medicine (Baltimore). 2020 Oct 16;99(42):e22433. DOI: 10.1097/MD.0000000000022433
    Back to article
  30. 30Yun Y, Wang Y, Hao Y, Xu L, Cai Q. The time course of chest CT lung changes in COVID-19 patients from onset to discharge. Eur J Radiol Open. 2021;8:100305. DOI: 10.1016/j.ejro.2020.100305
    Back to article
  31. 31Rathore SS, Hussain N, Manju AH, Wen Q, Tousif S, Avendaño-Capriles CA, et al. Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2022 Jan;94(1):229–39. DOI: 10.1002/jmv.27301
    Back to article
  32. 32Bemtgen X, Kaier K, Rilinger J, Rottmann F, Supady A, von Zur Mühlen C, et al. Myocarditis mortality with and without COVID-19: insights from a national registry. Clin Res Cardiol Off J Ger Card Soc. 2022 Dec 24;1–7. DOI: 10.1007/s00392-022-02141-9
    Back to article
  33. 33Pommier T, Benzenine E, Bernard C, Mariet AS, Béjot Y, Giroud M, et al. Trends of Myocarditis and Endocarditis Cases before, during, and after the First Complete COVID-19-Related Lockdown in 2020 in France. Biomedicines. 2022 May 25;10(6):1231. DOI: 10.3390/biomedicines10061231
    Back to article
  34. 34Fatuyi M, Amoah J, Egbuchiem H, Antia A, Akinti S, Mararenko A, et al. Impact of COVID-19 Infection on Clinical Outcomes Among Patients With Acute Decompensated Heart Failure: A Nationwide Analysis. Curr Probl Cardiol. 2023 Jul 1;48(11):101908. DOI: 10.1016/j.cpcardiol.2023.101908
    Back to article
  35. 35WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 Oct 6;324(13):1330–41. DOI: 10.1001/jama.2020.17023
    Back to article
  36. 36van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020 Dec 14;24(1):696. DOI: 10.1186/s13054-020-03400-9
    Back to article
  37. 37Covello RD, Pasin L, Fresilli S, Tóth K, Damiani C, Hajjar LA, et al. Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen. NEJM Evid. 2023 May;2(5):EVIDoa2200283. DOI: 10.1056/evidoa2200283
    Back to article
  38. 38Reis S, Popp M, Schießer S, Metzendorf MI, Kranke P, Meybohm P, et al. Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis. Thromb Res. 2022 Nov;219:40–8. DOI: 10.1016/j.thromres.2022.09.001
    Back to article
  39. 39Zong X, Wang X, Liu Y, Li Z, Wang W, Wei D, et al. Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials. Front Med. 2022 Sep 7;9:965790. DOI: 10.3389/fmed.2022.965790
    Back to article
  40. 40Sokolski M, Reszka K, Adamik B, Kilis-Pstrusinska K, Lis W, Pomorski M, et al. Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study. Sci Rep. 2024 Feb 28;14(1):4832. DOI: 10.1038/s41598-024-55407-9
    Back to article
  41. 41Howard-Jones AR, Huang S, Orde SR, Branley JM. Risk factors for mortality in severe COVID-19: Exploring the interplay of immunomodulatory therapy and coinfection. Anaesth Intensive Care. 2023 Sep 17;310057X231183451. DOI: 10.1177/0310057x231183451
    Back to article
  42. 42Bukhman G, Mocumbi AO, Atun R, Becker AE, Bhutta Z, Binagwaho A, et al. The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion. Lancet. 2020 Oct 3;396(10256):991–1044. DOI: 10.1016/s0140-6736(20)31907-3
    Back to article
  43. 43Baker TB, Bolt DM, Smith SS, Piasecki TM, Conner KL, Bernstein SL, et al. The Relationship of COVID-19 Vaccination with Mortality Among 86,732 Hospitalized Patients: Subpopulations, Patient Factors, and Changes over Time. J Gen Intern Med. 2023 Apr;38(5):1248–55. DOI: 10.1007/s11606-022-08007-0
    Back to article
DOI: https://doi.org/10.5334/gh.1403 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Sep 29, 2024
Accepted on: Feb 11, 2025
Published on: Feb 28, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
COVID-19,
SARS-CoV-2 virus,
men,
male,
mortality,
global differences,
Africa,
America,
Asia,
Europe

© 2025 Juan Esteban Gómez-Mesa, Juan Pablo Arango-Ibanez, Pablo Perel, Dorairaj Prabhakaran, Hoover O. León-Giraldo, Alejandro Toro-Pedroza, Ricardo Enrique Larrea Gómez, César J. Herrera, Julián Lugo-Peña, Liliana Patricia Cárdenas Alaz, Victor Rossel, Daniel Sierra-Lara, Jessica Mercedes, Clara Inés Saldarriaga-Giraldo, María Juliana Rodríguez-González, Armando Alvarado, Juan Carlos Ortega, Miguel Quintana Da Silva, Kavita Singh, Karen Sliwa, On behalf of the CARDIO COVID 19–20 and WHF CVD COVID-19 research groups, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 20 (2025): Issue 1Next article